Taken together, the findings presented here establish dorsal and median raphe serotonergic neurons and their projections as key drivers of glioma progression, offering new mechanistic insight and highlighting 5HT2A antagonism as a promising therapeutic strategy to disrupt neuron–glioma crosstalk and improve outcomes for these presently lethal brain cancers. The gene discussed is HTR2A; the disease is glioma.